Spinifex Pharmaceuticals Enhances CMC Team With Two Senior Appointments

Dr Peter Spargo joins as SVP, CMC and Dr Chris Richardson as Director CMC and Nonclinical Project Manager Melbourne, Australia and Stamford, USA - Spinifex Pharmaceuticals, a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has enhanced its Chemistry, Manufacturing & Controls capability as it continues to build the management team to drive the development of its lead candidate, EMA401, in a number of chronic pain indications. Dr Peter Spargo has joined Spinifex as Senior Vice President, CMC .

http://ift.tt/1DBqfBk